FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard Hochster, MD
Lead Site PI
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arizona Cancer Center
Tucson, Arizona, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
- University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States
- Kansas University Cancer Center
Westwood, Kansas, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Laura & Isaac Perlmutter Cancer Center at Nyu Langone Health
New York, New York, United States
- Swedish Cancer Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Dec 2019
- Primary completion
- 31 Dec 2024
- Completion
- 31 Jan 2025
- Last update posted
- 27 Jul 2023
- Registered enrollment
- 27
- Registry id
- NCT04169347
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.